After 48 h, these mice were treated with a daily intraperitoneal injection of JMF4073 for 14 days (Fig
Downregulated in HCC 31,32,33 , HNF4 is considered as a tumor suppressor that represses the development of HCC and inhibit epithelial-mesenchymal transition (EMT), a process that promotes cancer progression and metastasis 34,35,36
however, treatment directed at increasing HDL-C levels has not proven to reduce the risk of ASCVD [10, 16]
Discontinue use if you experience any adverse reactions
Who Should NOT Start GLP-1 Treatment and Safety Considerations Absolute contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2 syndrome, or severe hypersensitivity to GLP-1 receptor agonists